Clonidine, an α‐adrenoceptor agonist, reduces human plasma melatonin levels when administered intravenously at 2–3 (μg kg−1 to sleeping volunteers. Measurement of plasma melatonin levels after administration of clonidine could be the basis for a clinical in‐vivo test of α‐adrenoceptors.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of Pharmacy and Pharmacology|
|State||Published - Jul 1986|
ASJC Scopus subject areas
- Pharmaceutical Science